A randomized, double-blind study comparing the efficacy and safety of Trazodone OAD and venlafaxine XR in the treatment of patients with Major Depressive Disorder
Latest Information Update: 07 Oct 2020
At a glance
- Drugs Trazodone (Primary) ; Venlafaxine
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Angelini Group
- 15 Sep 2020 Results from NCT02086929 and other study evaluating the efficacy of once a day trazodone in patients with major depressive disorder, presented at the 33rd Annual Congress of the European College of Neuropsychopharmacology
- 15 Jan 2020 Results published in the International Clinical Psychopharmacology
- 29 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.